Clinical features, treatment, and outcome in 102 adult and pediatric patients with localized high-grade synovial sarcoma. - Wikidata - awgldk - TriplyDB

Clinical features, treatment, and outcome in 102 adult and pediatric patients with localized high-grade synovial sarcoma.

Clinical features, treatment, and outcome in 102 adult and pediatric patients with localized high-grade synovial sarcoma.

http://www.wikidata.org/entity/Q41963479

about

Multidisciplinary management of soft tissue sarcoma Synovial sarcoma: recent discoveries as a roadmap to new avenues for therapy Developing an Evidence-based Followup Schedule for Bone Sarcomas Based on Local Recurrence and Metastatic Progression.Response to chemotherapy is not related to chromosome instability in synovial sarcoma.Perioperative radiotherapy is associated with improved survival among patients with synovial sarcoma: A SEER analysis.Truncated SSX protein suppresses synovial sarcoma cell proliferation by inhibiting the localization of SS18-SSX fusion protein.The Role of (18)F-FDG PET/CT as a Prognostic Factor in Patients with Synovial Sarcoma Age as an independent prognostic factor for survival of localised synovial sarcoma patients A Pilot Study of Anti-CTLA4 Antibody Ipilimumab in Patients with Synovial Sarcoma.HMGB1-mediated autophagy decreases sensitivity to oxymatrine in SW982 human synovial sarcoma cells The challenge of access to care for soft tissue sarcomas bridging pediatric and adult age: the Italian pediatric oncology view.Current status of engineered T-cell therapy for synovial sarcoma.Topotecan and cyclophosphamide in adults with relapsed sarcoma.Primary synovial sarcoma of the parapharyngeal space: a clinicopathologic study of five cases Cutaneous Metastases Arising from Synovial Sarcoma: A Case Report.Synovial sarcoma of the shoulder: A series of 14 cases.Na+ entry through heteromeric TRPC4/C1 channels mediates (-)Englerin A-induced cytotoxicity in synovial sarcoma cells.PIEZO1 Channel Is a Potential Regulator of Synovial Sarcoma Cell-Viability.

P2860

Q26825028-7B908FAB-E5D8-4C57-9C69-0BA141F29CCD Q28087134-E366EC80-A749-45F4-BC77-0D52293A85BB Q33276119-A8113140-4DB1-4581-9846-E3FC5A4CAA40 Q34395325-8115C989-36D6-462A-8D0E-3564F11E6B1C Q34664193-C3956695-25AA-43D9-BED4-A55B70F7293A Q35018901-4FC79706-EA53-48FF-9D7E-C3FD53C21FBC Q35162720-E766BA25-9173-4F45-8504-6F949C83B4BB Q36443884-F9184492-97C2-42D1-B21A-A9EB226FDF72 Q36716591-9E6288DD-834A-4A20-816C-597A4C07F078 Q37449536-3FCA25A0-3850-4476-853F-3A8995DE526B Q37982451-5DEFA5B5-9615-497A-B053-1A38DE90AC3D Q38916522-F3EC08E0-3050-49E6-AB53-48EE7CE2C245 Q40278945-037F2109-9B39-459A-8650-E1E0D1BB4CC7 Q41764856-EB9F328F-1A4D-4795-949E-A68BAC54A2FF Q47126064-A303D04F-2243-44E8-B624-051EE568978D Q47428660-AD07B697-8CE6-44D4-B99C-27FCFF3DA698 Q48172320-0FDE8804-48AA-4E2A-9A1F-F5A7DDC13466 Q55044707-936EAAD9-F573-40EA-B114-553246E2075D

P2860

Clinical features, treatment, and outcome in 102 adult and pediatric patients with localized high-grade synovial sarcoma.

http://www.wikidata.org/entity/Q41963479

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Clinical features, treatment, ...... d high-grade synovial sarcoma.

@en

type

label

Clinical features, treatment, ...... d high-grade synovial sarcoma.

@en

prefLabel

Clinical features, treatment, ...... d high-grade synovial sarcoma.

@en

P1433

Q41963479-770671FE-4379-48A4-9F89-CE544E5CEA77

P1476

Q41963479-6AAC010C-0A01-4D67-986F-5893960B991C

P2093

Q41963479-01A8F9FF-4362-4BD4-9214-A19487B840C8

Q41963479-0387FA8C-B724-4CF0-AAFB-28F54185457F

Q41963479-0E451BAE-480F-4A3A-8731-0C6F7836BDA7

Q41963479-3E8F6C1D-86A3-4603-A12C-9A3281B7B83E

Q41963479-5B269ED9-0310-4CF4-A7E2-BEDD8B6960B3

Q41963479-695C0412-5BB9-4111-B5FA-F8D8184C5226

Q41963479-9BB567EA-0BB4-4631-B6BE-69C9F1084F26

Q41963479-B1676E76-9A8C-4C12-BD54-65B085BF6DDB

Q41963479-BE1F4418-C543-4CCB-A41C-B04B7A81D29F

Q41963479-C31C52A9-6F7C-4F02-A170-925FD21CF9C0

P2860

Q41963479-02E111C1-2C22-482E-824E-116E83DA4292

Q41963479-0F572C49-B599-41DD-8C86-2AD0C1852D55

Q41963479-120B8166-F2DA-47A9-81B0-96F20CCE8530

Q41963479-1359947A-6559-4A38-8473-D1AC191896B5

Q41963479-1A575656-B407-4703-BBF7-E8699CF567DD

Q41963479-1B9F2515-F64A-4625-AD90-F03CD833DFD8

Q41963479-22360E89-554F-48DF-BBCF-9FDEF72D7787

Q41963479-34895CBB-789F-4D0D-9040-B32FE1F16D50

Q41963479-38D447D5-1E15-4818-B8AD-BC40785C702A

Q41963479-4031A020-C80E-4F6F-AC5B-568C5CD569B6

P304

Q41963479-91270ED7-213F-4075-98AF-138B742FCBC3

P31

Q41963479-42575995-B5C2-4015-A394-B88F42E92305

P356

Q41963479-F2E898CF-095F-4B83-B2FD-464F2F278462

P478

Q41963479-EDE3798D-DED3-4E71-B319-8E19BF2FD354

P50

Q41963479-194CF124-B984-4EE6-9064-982F27468589

Q41963479-44C06704-EA3F-4348-979A-135AC21E8A12

Q41963479-5C172A67-1FBC-4984-AAEC-72C26FFE888D

P577

Q41963479-EB3026D2-365A-4FB3-B2B4-BEA7A38A51C4

P5875

Q41963479-7F1DB96F-55F9-400C-9FE1-4A82B1A7A44E

P698

Q41963479-3D189A73-A263-4A0A-8F71-191667ED9EC4

P932

Q41963479-22766C4D-5414-42C5-B412-FB235389E01D

P356

P1433

P1476

Clinical features, treatment, ...... ed high-grade synovial sarcoma

@en

P2093

A A Gupta

http://www.w3.org/2001/XMLSchema#string

C N Catton

http://www.w3.org/2001/XMLSchema#string

D Hodgson

http://www.w3.org/2001/XMLSchema#string

D Hogg

http://www.w3.org/2001/XMLSchema#string

H Al-Hussaini

http://www.w3.org/2001/XMLSchema#string

J S Wunder

http://www.w3.org/2001/XMLSchema#string

M E Blackstein

http://www.w3.org/2001/XMLSchema#string

P C Ferguson

http://www.w3.org/2001/XMLSchema#string

R Kandel

http://www.w3.org/2001/XMLSchema#string

S Hopyan

http://www.w3.org/2001/XMLSchema#string

P2860

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial.

Randomized phase II evaluation of 6 g/m2 of ifosfamide plus doxorubicin and granulocyte colony-stimulating factor (G-CSF) compared with 12 g/m2 of ifosfamide plus doxorubicin and G-CSF in the treatment of poor-prognosis soft tissue sarcoma.

Synovial sarcoma: a multivariate analysis of prognostic factors in 112 patients with primary localized tumors of the extremity.

Radiologist review versus group peer review of claimed responses in a phase II study on high-dose ifosfamide in advanced soft tissue sarcomas of the adult: a study of the EORTC Soft Tissue and Bone Sarcoma Group.

Synovial sarcoma: a clinicopathologic, staging, and prognostic assessment.

Radiographic and histologic response to neoadjuvant radiotherapy in patients with soft tissue sarcoma

Synovial sarcoma in children: surgical lessons from a single institution and review of the literature.

Synovial sarcoma of childhood and adolescence: a multicenter, multivariate analysis of outcome.

Ifosfamide in the adjuvant therapy of soft tissue sarcomas.

P304

231789

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2011/231789

http://www.w3.org/2001/XMLSchema#string

P478

2011

http://www.w3.org/2001/XMLSchema#string

P50

Brian O'Sullivan

Anthony M Griffin

P577

2011-04-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51114327

http://www.w3.org/2001/XMLSchema#string

P698

21559258

http://www.w3.org/2001/XMLSchema#string

P932

3087894

http://www.w3.org/2001/XMLSchema#string